Biogen

$266.92
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.73 (+0.27%) As of 5:16 PM UTC today

Why Robinhood?

You can buy or sell Biogen and other stocks, options, and ETFs commission-free!

About BIIB

Biogen Inc. Common Stock, also called Biogen, is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases.

CEO

Michel Vounatsos

Employees

9,100

Headquarters

Cambridge, Massachusetts

Founded

1978

Market Cap

41.11B

Price-Earnings Ratio

10.60

Dividend Yield

—

Average Volume

966.39K

High Today

$270.27

Low Today

$264.63

Open Price

$267.39

Volume

292.31K

52 Week High

$363.92

52 Week Low

$223.25

BIIB News

BenzingaApr 8

Biogen, Bio-Thera Ink Licensing Agreement For Development Of Actemra-Based Biosimilar For Rheumatoid Arthritis

Biogen Inc (NASDAQ: BIIB) and Bio-Thera Solutions Ltd have entered into a commercialization and license agreement to develop, manufacture, and commercialize BAT

Analyst Ratings

38%

of 32 ratings

Buy

38%

Hold

44%

Sell

19%

BIIB Earnings

$0.00

$3.42

$6.84

$10.26

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Available Apr 22, Pre-Market